Differential Diagnosis of Recurrent Hypoglycemia
Before pursuing any differential diagnosis, you must first document Whipple's triad: symptoms/signs consistent with hypoglycemia, a low plasma glucose concentration, and resolution of symptoms after glucose administration 1. Without documented Whipple's triad, do not proceed with hypoglycemia workup 2, 1.
Algorithmic Approach to Differential Diagnosis
Step 1: Diabetic vs. Non-Diabetic Patient
In diabetic patients, the differential is straightforward—insulin or insulin secretagogue therapy (sulfonylureas, meglitinides) causes the vast majority of recurrent hypoglycemia 3, 4. Prior hypoglycemic events, especially level 2 or 3 events, are the strongest predictor of recurrence 3, 4. Key risk factors include:
- Medication-related: Insulin (highest risk), followed by basal insulin, followed by sulfonylureas/meglitinides 3
- Patient factors: Age ≥75 years in type 2 diabetes, impaired hypoglycemia awareness, chronic kidney disease, cognitive impairment 3, 4
- Tight glycemic control: Both low and high A1C paradoxically increase risk (J-shaped relationship) 3
Step 2: Non-Diabetic Patients—Pursue Clinical Clues First
In non-diabetic patients, systematically evaluate these categories in order 1:
A. Exogenous Causes (Rule Out First)
- Drugs: Any hypoglycemic agents, alcohol, quinolones, pentamidine
- Accidental, surreptitious, or malicious hypoglycemia: Consider factitious disorder
B. Critical Illnesses
- Sepsis, liver failure, renal failure, cardiac failure
- Malnutrition, prolonged fasting
C. Hormone Deficiencies
- Cortisol insufficiency (including hypopituitarism)
- Glucagon deficiency
- Growth hormone deficiency
D. Non-Islet Cell Tumors
- NICTH (Non-Islet Cell Tumor Hypoglycemia): Large tumors secreting Big-IGF2 5
- Characterized by low insulin, low C-peptide, and low IGF-1 levels
Step 3: If Above Causes Excluded—Endogenous Hyperinsulinism Workup
When clinical clues are absent, obtain these labs during a documented hypoglycemic episode 1:
- Plasma glucose
- Insulin
- C-peptide
- Proinsulin
- β-hydroxybutyrate
- Circulating oral hypoglycemic agents (screen for surreptitious use)
- Insulin antibodies (separate measurement) 1
Interpretation Pattern:
High insulin + High C-peptide = Endogenous hyperinsulinism:
- Insulinoma (most common)
- Nesidioblastosis (rare) 2
- Post-bariatric/gastric surgery hypoglycemia 5
- Monogenic causes: Glucokinase-activating mutations, insulin receptor mutations (typically postprandial) 5
High insulin + Low C-peptide = Exogenous insulin administration (factitious)
Low insulin + Low C-peptide = Non-insulin mediated:
- NICTH (check IGF-2)
- Inborn errors of metabolism 5
Step 4: Rare/Genetic Causes (If Standard Workup Negative)
Timing of hypoglycemia guides diagnosis 5:
Fasting Hypoglycemia:
- Glycogen storage disorders (types 0, I, III)
- Fatty acid oxidation disorders
- Gluconeogenesis disorders
- Look for: hepatomegaly, rhabdomyolysis after fasting/exercise, cardiomyopathy, family history 5
Postprandial Hypoglycemia:
- Inherited fructose intolerance
- Exercise-induced hyperinsulinism (SLC16A1 gene mutation) 5
- Glucokinase or insulin receptor mutations 5
Autoimmune Causes:
- Hirata syndrome: Anti-insulin antibodies (especially with Graves' disease) 2, 5
- Anti-insulin receptor antibodies 5
Critical Pitfalls to Avoid
Do not pursue hypoglycemia workup without documented Whipple's triad—symptoms are nonspecific and common 2, 1
Screen for impaired hypoglycemia awareness annually in at-risk patients by asking: "Do you ever have low blood glucose without feeling symptoms?" 3, 4. This dramatically increases risk for severe hypoglycemia and recurrence.
Always screen for surreptitious use of insulin or oral agents during workup—measure circulating hypoglycemic agents and check insulin antibodies 1
Consider timing: Fasting vs. postprandial vs. exercise-induced hypoglycemia narrows the differential significantly 5
In diabetic patients, assess hypoglycemia history at every encounter—prior events are the strongest predictor of recurrence 3, 4